![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » UK Authorizes Dexamethasone as COVID-19 Treatment
UK Authorizes Dexamethasone as COVID-19 Treatment
![UKflag.jpg](https://www.fdanews.com/ext/resources/test/Drug-Images4/UKflag.jpg?t=1586293848&width=430)
The UK has authorized the use of the corticosteroid dexamethasone to reduce the risk of death in COVID-19 patients requiring ventilation or oxygen.
The UK government cited preliminary results from Oxford University’s RECOVERY trial, which showed that dexamethasone reduced the risk of death in ventilated patients by one-third, and by one-fifth in patients on oxygen.
The government said it is securing a supply of the drug for the treatment of more than 200,000 COVID-19 patients.
Upcoming Events
-
21Oct